102 related articles for article (PubMed ID: 17261135)
1. Effect of a novel phyto-compound on mucosal candidiasis: further evidence from an ex vivo study.
Nakajima J; Papaah P; Yoshizawa M; Marotta F; Nakajima T; Mihara S; Minelli E
J Dig Dis; 2007 Feb; 8(1):48-51. PubMed ID: 17261135
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and antifungal susceptibility of yeasts obtained from the oral cavity of elderly individuals.
de Resende MA; de Sousa LV; de Oliveira RC; Koga-Ito CY; Lyon JP
Mycopathologia; 2006 Jul; 162(1):39-44. PubMed ID: 16830190
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Salvia AC; Figueiredo MS; Braga JA; Pereira DF; Brighenti FL; Koga-Ito CY
J Oral Pathol Med; 2013 Aug; 42(7):570-5. PubMed ID: 23278631
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus.
Bremenkamp RM; Caris AR; Jorge AO; Back-Brito GN; Mota AJ; Balducci I; Brighenti FL; Koga-Ito CY
Arch Oral Biol; 2011 Jun; 56(6):549-55. PubMed ID: 21183157
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
Migliorati CA; Birman EG; Cury AE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
[TBL] [Abstract][Full Text] [Related]
7. Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naïve HIV-infected patients.
Patel M; Shackleton JA; Coogan MM; Galpin J
AIDS Patient Care STDS; 2008 Aug; 22(8):613-8. PubMed ID: 18627277
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of fungi of the genus Candida to antifungal drugs].
Sheremet ZA; Volosevich LI
Antibiot Khimioter; 1989 Apr; 34(4):263-6. PubMed ID: 2751383
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of linalool in cases of Candida spp. isolated from individuals with oral candidiasis.
Dias IJ; Trajano ERIS; Castro RD; Ferreira GLS; Medeiros HCM; Gomes DQC
Braz J Biol; 2018 May; 78(2):368-374. PubMed ID: 28977047
[TBL] [Abstract][Full Text] [Related]
10. In view of an optimal gut antifungal therapeutic strategy: an in vitro susceptibility and toxicity study testing a novel phyto-compound.
Metugriachuk Y; Kuroi O; Pavasuthipaisit K; Tsuchiya J; Minelli E; Okura R; Fesce E; Marotta F
Chin J Dig Dis; 2005; 6(2):98-103. PubMed ID: 15904429
[TBL] [Abstract][Full Text] [Related]
11. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
[TBL] [Abstract][Full Text] [Related]
12. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
Ellepola AN
Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
[TBL] [Abstract][Full Text] [Related]
14. Incidence rate of Candida species in the oral cavity of middle-aged and elderly subjects.
Zaremba ML; Daniluk T; Rozkiewicz D; Cylwik-Rokicka D; Kierklo A; Tokajuk G; Dabrowska E; Pawińska M; Klimiuk A; Stokowska W; Abdelrazek S
Adv Med Sci; 2006; 51 Suppl 1():233-6. PubMed ID: 17458099
[TBL] [Abstract][Full Text] [Related]
15. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
[TBL] [Abstract][Full Text] [Related]
16. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients].
Dieng Y; Faye-Niang MA; Ndour-Diop A; Sow PS; Dieng T; Soumare M; Bah IB; Faye O; Diop BM; Gaye O; Ndir O; Diallo S
Dakar Med; 2001; 46(1):4-7. PubMed ID: 15773146
[TBL] [Abstract][Full Text] [Related]
17. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
Yan Z; Young AL; Hua H; Xu Y
J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
[TBL] [Abstract][Full Text] [Related]
18. Oral microflora and their relation to risk factors in HIV+ patients with oropharyngeal candidiasis.
Sharifzadeh A; Khosravi AR; Shokri H; Asadi Jamnani F; Hajiabdolbaghi M; Ashrafi Tamami I
J Mycol Med; 2013 Jun; 23(2):105-12. PubMed ID: 23721997
[TBL] [Abstract][Full Text] [Related]
19. Isolation of Candida dubliniensis in denture stomatitis.
Marcos-Arias C; Vicente JL; Sahand IH; Eguia A; De-Juan A; Madariaga L; Aguirre JM; Eraso E; Quindós G
Arch Oral Biol; 2009 Feb; 54(2):127-31. PubMed ID: 18950745
[TBL] [Abstract][Full Text] [Related]
20. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
